Real-time enrollment status for this t cell non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:03 AM UTC
| NCT Number | NCT06420089 |
| Recruiting Status | Recruiting |
| Condition | T Cell Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Vittoria Biotherapeutics |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 18, 2026: Clinical trial NCT06420089 is currently recruiting participants. This phase1 study for t cell non-hodgkin lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Vittoria Biotherapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06420089 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06420089 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.